Persons with dispensed medicines; origin

Edit table Download table Show description

Persons with dispensed medicines; origin
Sex Age Origin Medicine group (ATC) Periods Persons with medicines, relative (%) Defined daily doses (DDD), relative (number per 1 000 persons)
Total male and female Total age Total C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Total G02B Contraceptives for topical use 2021* 0.10 1,658
Total male and female Total age Total G03A Hormonal contraceptives system. use 2021* 1.81 6,377
Total male and female Total age Origin: born in the Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin: born in the Netherlands G02B Contraceptives for topical use 2021* 0.12 1,879
Total male and female Total age Origin: born in the Netherlands G03A Hormonal contraceptives system. use 2021* 2.05 7,236
Total male and female Total age Origin: born in NL, parents in NL C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin: born in NL, parents in NL G02B Contraceptives for topical use 2021* 0.12 1,955
Total male and female Total age Origin: born in NL, parents in NL G03A Hormonal contraceptives system. use 2021* 2.07 7,422
Total male and female Total age Origin: born in NL, parent(s) outside NL C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin: born in NL, parent(s) outside NL G02B Contraceptives for topical use 2021* 0.10 1,394
Total male and female Total age Origin: born in NL, parent(s) outside NL G03A Hormonal contraceptives system. use 2021* 1.86 6,039
Total male and female Total age Origin: born in NL, 1 parent born in NL C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin: born in NL, 1 parent born in NL G02B Contraceptives for topical use 2021* 0.13 2,017
Total male and female Total age Origin: born in NL, 1 parent born in NL G03A Hormonal contraceptives system. use 2021* 2.31 7,903
Total male and female Total age Origin: born in NL, parents born abroad C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin: born in NL, parents born abroad G02B Contraceptives for topical use 2021* 0.05 629
Total male and female Total age Origin: born in NL, parents born abroad G03A Hormonal contraceptives system. use 2021* 1.31 3,750
Total male and female Total age Origin: born outside the Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin: born outside the Netherlands G02B Contraceptives for topical use 2021* 0.03 400
Total male and female Total age Origin: born outside the Netherlands G03A Hormonal contraceptives system. use 2021* 0.47 1,488
Total male and female Total age Origin country: The Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: The Netherlands G02B Contraceptives for topical use 2021* 0.12 1,955
Total male and female Total age Origin country: The Netherlands G03A Hormonal contraceptives system. use 2021* 2.07 7,422
Total male and female Total age Origin country: outside The Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: outside The Netherlands G02B Contraceptives for topical use 2021* 0.06 831
Total male and female Total age Origin country: outside The Netherlands G03A Hormonal contraceptives system. use 2021* 1.08 3,463
Total male and female Total age Origin country: Europe (excl. NL) C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: Europe (excl. NL) G02B Contraceptives for topical use 2021* 0.07 1,084
Total male and female Total age Origin country: Europe (excl. NL) G03A Hormonal contraceptives system. use 2021* 1.14 3,865
Total male and female Total age Origin country: outside Europe C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: outside Europe G02B Contraceptives for topical use 2021* 0.05 707
Total male and female Total age Origin country: outside Europe G03A Hormonal contraceptives system. use 2021* 1.04 3,265
Total male and female Total age Origin country: Morocco C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: Morocco G02B Contraceptives for topical use 2021* 0.02 217
Total male and female Total age Origin country: Morocco G03A Hormonal contraceptives system. use 2021* 0.63 1,686
Total male and female Total age Origin country: Turkey C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: Turkey G02B Contraceptives for topical use 2021* 0.02 253
Total male and female Total age Origin country: Turkey G03A Hormonal contraceptives system. use 2021* 0.68 1,868
Total male and female Total age Origin country: Suriname C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: Suriname G02B Contraceptives for topical use 2021* 0.06 827
Total male and female Total age Origin country: Suriname G03A Hormonal contraceptives system. use 2021* 1.54 4,901
Total male and female Total age Origin country: Dutch Caribbean C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: Dutch Caribbean G02B Contraceptives for topical use 2021* 0.09 1,227
Total male and female Total age Origin country: Dutch Caribbean G03A Hormonal contraceptives system. use 2021* 1.91 6,214
Total male and female Total age Origin country: Indonesia C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: Indonesia G02B Contraceptives for topical use 2021* 0.03 343
Total male and female Total age Origin country: Indonesia G03A Hormonal contraceptives system. use 2021* 0.39 1,314
Total male and female Total age Origin country: outside Europe (exc. 5.. C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female Total age Origin country: outside Europe (exc. 5.. G02B Contraceptives for topical use 2021* 0.07 996
Total male and female Total age Origin country: outside Europe (exc. 5.. G03A Hormonal contraceptives system. use 2021* 1.22 3,880
Total male and female 0 to 14 years Total C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Total G02B Contraceptives for topical use 2021* 0.00 23
Total male and female 0 to 14 years Total G03A Hormonal contraceptives system. use 2021* 0.52 1,448
Total male and female 0 to 14 years Origin: born in the Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin: born in the Netherlands G02B Contraceptives for topical use 2021* 0.00 24
Total male and female 0 to 14 years Origin: born in the Netherlands G03A Hormonal contraceptives system. use 2021* 0.53 1,497
Total male and female 0 to 14 years Origin: born in NL, parents in NL C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin: born in NL, parents in NL G02B Contraceptives for topical use 2021* 0.00 26
Total male and female 0 to 14 years Origin: born in NL, parents in NL G03A Hormonal contraceptives system. use 2021* 0.62 1,770
Total male and female 0 to 14 years Origin: born in NL, parent(s) outside NL C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin: born in NL, parent(s) outside NL G02B Contraceptives for topical use 2021* 0.00 18
Total male and female 0 to 14 years Origin: born in NL, parent(s) outside NL G03A Hormonal contraceptives system. use 2021* 0.25 648
Total male and female 0 to 14 years Origin: born in NL, 1 parent born in NL C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin: born in NL, 1 parent born in NL G02B Contraceptives for topical use 2021* 0.00 30
Total male and female 0 to 14 years Origin: born in NL, 1 parent born in NL G03A Hormonal contraceptives system. use 2021* 0.37 1,006
Total male and female 0 to 14 years Origin: born in NL, parents born abroad C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin: born in NL, parents born abroad G02B Contraceptives for topical use 2021* 0.00 6
Total male and female 0 to 14 years Origin: born in NL, parents born abroad G03A Hormonal contraceptives system. use 2021* 0.12 279
Total male and female 0 to 14 years Origin: born outside the Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin: born outside the Netherlands G02B Contraceptives for topical use 2021* 0.00 11
Total male and female 0 to 14 years Origin: born outside the Netherlands G03A Hormonal contraceptives system. use 2021* 0.27 696
Total male and female 0 to 14 years Origin country: The Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: The Netherlands G02B Contraceptives for topical use 2021* 0.00 26
Total male and female 0 to 14 years Origin country: The Netherlands G03A Hormonal contraceptives system. use 2021* 0.62 1,770
Total male and female 0 to 14 years Origin country: outside The Netherlands C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: outside The Netherlands G02B Contraceptives for topical use 2021* 0.00 16
Total male and female 0 to 14 years Origin country: outside The Netherlands G03A Hormonal contraceptives system. use 2021* 0.26 658
Total male and female 0 to 14 years Origin country: Europe (excl. NL) C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Europe (excl. NL) G02B Contraceptives for topical use 2021* 0.00 10
Total male and female 0 to 14 years Origin country: Europe (excl. NL) G03A Hormonal contraceptives system. use 2021* 0.32 875
Total male and female 0 to 14 years Origin country: outside Europe C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: outside Europe G02B Contraceptives for topical use 2021* 0.00 19
Total male and female 0 to 14 years Origin country: outside Europe G03A Hormonal contraceptives system. use 2021* 0.23 571
Total male and female 0 to 14 years Origin country: Morocco C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Morocco G02B Contraceptives for topical use 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Morocco G03A Hormonal contraceptives system. use 2021* 0.12 277
Total male and female 0 to 14 years Origin country: Turkey C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Turkey G02B Contraceptives for topical use 2021* 0.00 25
Total male and female 0 to 14 years Origin country: Turkey G03A Hormonal contraceptives system. use 2021* 0.18 409
Total male and female 0 to 14 years Origin country: Suriname C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Suriname G02B Contraceptives for topical use 2021* 0.00 43
Total male and female 0 to 14 years Origin country: Suriname G03A Hormonal contraceptives system. use 2021* 0.45 1,152
Total male and female 0 to 14 years Origin country: Dutch Caribbean C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Dutch Caribbean G02B Contraceptives for topical use 2021* 0.00 48
Total male and female 0 to 14 years Origin country: Dutch Caribbean G03A Hormonal contraceptives system. use 2021* 0.42 1,085
Total male and female 0 to 14 years Origin country: Indonesia C05C Capillary stabilizing agents 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Indonesia G02B Contraceptives for topical use 2021* 0.00 0
Total male and female 0 to 14 years Origin country: Indonesia G03A Hormonal contraceptives system. use 2021* 0.29 695
Total male and female 0 to 14 years Origin country: outside Europe (exc. 5.. C05C Capillary stabilizing agents 2021* 0.00 0
Source: CBS.
Explanation of symbols

Dataset is not available.


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, origin, age and sex.

Data available from 2020.

Status of the figures:
All figures are provisional.

Changes as of 22 February, 2023:
'Origin: total' and 'Origin country: total' are replaced with one total.

When will new figures be published?
New figures will be published in the last quarter of 2023.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.
Defined daily doses (DDD), relative
Defined Daily Dose (DDD) is de door de WHO vastgestelde gemiddelde dagelijkse dosis van een geneesmiddel, wanneer het geneesmiddel wordt ingezet voor de hoofdindicatie, bij een onderhoudsbehandeling voor volwassenen. Deze definitie maakt het mogelijk om het gebruik van verschillende toedieningsvormen en verschillende middelen met elkaar te vergelijken.

WHO: World Health Organisation, Wereldgezondheidsorganisatie